Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-06-22

Clinical Trial Update: Defining the Physiological Mechanisms of Risk Genes for Hyperglycaemia, Insulin Resistance and Type 2 Diabetes

View source ↗

Summary

An update on a University of Oxford clinical study investigating how genetic risk factors contribute to hyperglycemia, insulin resistance and type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Oxford | Conditions: Type 2 Diabetes | Status: UNKNOWN